Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Explore when bonds may be preferred over the Sp500 in retirement and how a cautious mix can protect assets while supporting withdrawals. This intro covers key timing considerations and conservative principles.
23,766 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Oceaneering International has staged a striking rally, with a fund-backed bet signaling confidence in continued growt...
Title insurance premium volume surged nearly 14% in 2025, driven by stronger mortgage activity and ongoing demand for...
Mel Robbins, the millionaire podcaster, pushes back against the Gen Z lazy stereotype, arguing that today’s young wor...
Berkshire Hathaway has been selling some positions, but a single airline stock remains a headline-grabber. This artic...
PayPal remains a leader in digital payments, but its stock faces volatility as growth slows. This guide helps you dec...
Hyperliquid launches macro prediction markets, including May CPI and June Fed rate bets, while HYPE breaks above $64....
An activist investor’s purchase often signals interest in a company’s next chapter. Read how Edward Garden’s stake co...
A public clash over strategy and governance wrapped up for now, but 2026 could be a real test for lululemon. This inv...
Traders online are buzzing about turns $100k $1.28m year as a 3x semiconductor play surged over the last 12 months. T...
Bitcoin sits at a crossroads as whales accumulate and policy debates heat up. This piece breaks down how many BTC cou...
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...